EUVIMEDEUVIMED entdecken
Open Access

Managing Cancer and Living Meaningfully in adults with brain metastases: A NIH ORBIT model phase II feasibility and proof-of-concept trial

Ashlee R Loughan iD, Autumn Lanoye iD, Kelcie Willis, Sarah Ellen Braun iD, Alexandria Davies, Gary Rodin iD, Leroy Thacker, Amber Fox, Christopher Kleva, Giuliana Zarrella, Suzanne Mazzeo, Dace Svikis und 1 weitere

Neuro-Oncology Practice · 17.03.2025 · 12 (2) · 271-280

DOI: 10.1093/nop/npae097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Practice, online erschienen am 15.10.2024. Verfasst von Ashlee R Loughan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Massey Comprehensive Cancer Center, Richmond, Virginia, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Managing Cancer and Living Meaningfully (CALM) is a brief, evidence-based psychotherapy designed to help patients with advanced cancer cope with the practical and profound challenges of their illness. However, no study has systematically examined CALM in adults with brain metastases, despite the well-documented incidence of distress in this growing population. The primary aim of this trial was to assess the feasibility and acceptability of CALM in adults with brain metastases.

Methods

Patients with brain metastases (N = 13) and elevated symptoms of depression and/or death anxiety enrolled in this single-arm trial. CALM was administered in 6 biweekly sessions, with outcomes assessed at baseline and post-intervention. Feasibility was assessed based on established metrics including enrollment and retention rates. Acceptability was measured by post-session surveys and post-intervention interviews. Preliminary signal change on measures of psychological distress was explored.

Results

Of the 13 enrolled participants, 11 completed baseline assessments and initiated treatment: 73% female, Mage = 58 years (SD = 12.9; range = 37–75). Nine completed the study (81% retention rate). Overall, participants reported high perceived benefits and would recommend the program to others. Baseline to post-intervention assessments indicated improvements in depression, death anxiety, generalized anxiety, post-traumatic stress, suicidal ideation, and spiritual well-being. Life quality, substance use, and fear of cancer recurrence remained relatively stable.

Conclusions

CALM is feasible and acceptable and may improve psychological distress in adults with brain metastases. The findings of this study align with our previous trial of patients with malignant glioma and support a future National Institute of Health Obesity Related Behavioral Intervention Trials phase II randomized pilot trial of CALM in neuro-oncology. Trial Registration Number NCT05087095 registered on March 23, 2022.

Schlagwörter

Stichwörter der Autor:innen

CALMacceptabilitybrain metastasesdeath anxietydepressionfeasibilitypsychotherapy

Autor:innen und Institutionen

  • Massey Comprehensive Cancer Center, Richmond, Virginia, USA.
  • School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Department of Psychology, Virginia Commonwealth University, Richmond, Virginia, USA.
  • McGuire Veterans Hospital, Richmond, Virginia, USA.

ORCID-Profile: Ashlee R Loughan, Autumn Lanoye, Sarah Ellen Braun, Gary Rodin

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • Congressionally Directed Medical Research Programs
  • Peer-Reviewed Cancer Research Program
  • NCRR
  • Dana-Farber/ Harvard Cancer Center T32 Training in Oncology Population Sciences

Zitieren

APA

Loughan, A. R., Lanoye, A., Willis, K., Braun, S. E., Davies, A., Rodin, G., Thacker, L., Fox, A., Kleva, C., Zarrella, G., Mazzeo, S., Svikis, D., & Swartz, L. (2025). Managing Cancer and Living Meaningfully in adults with brain metastases: A NIH ORBIT model phase II feasibility and proof-of-concept trial. Neuro-Oncology Practice, 12(2), 271-280. https://doi.org/10.1093/nop/npae097

Vancouver

Loughan AR, Lanoye A, Willis K, Braun SE, Davies A, Rodin G, et al. Managing Cancer and Living Meaningfully in adults with brain metastases: A NIH ORBIT model phase II feasibility and proof-of-concept trial. Neuro-Oncology Practice. 2025;12(2):271-280. doi:10.1093/nop/npae097

BibTeX
@article{Loughan2025,
  author = {Loughan, Ashlee R and Lanoye, Autumn and Willis, Kelcie and Braun, Sarah Ellen and Davies, Alexandria and Rodin, Gary and Thacker, Leroy and Fox, Amber and Kleva, Christopher and Zarrella, Giuliana and Mazzeo, Suzanne and Svikis, Dace and Swartz, Leigh},
  title = {Managing Cancer and Living Meaningfully in adults with brain metastases: A NIH ORBIT model phase II feasibility and proof-of-concept trial},
  journal = {Neuro-Oncology Practice},
  year = {2025},
  volume = {12},
  number = {2},
  pages = {271--280},
  doi = {10.1093/nop/npae097}
}
Kostenlos starten →